Axim Biotech (OTCQB: AXIM) CEO John Huemoeller joined Steve Darling from Proactive with news the company is working on a number of initiatives around protecting people from COVID-19. One of those is a much better facemask and Huemoeller explains how.

Huemoeller also told Proactvioe about a rapid test kit they are working on that will allow better screening for when people need to give the gift of life, donating blood.



Read the Full Article